Dithio-CN03
Dithio-CN03 is a compound with the highest neuroprotective efficacy. Dithio-CN03 fights the progression of retinitis pigmentosa (RP) by inhibiting the cGMP mediated signaling pathway and reducing photoreceptor cell death. Dithio-CN03 can be used in research into RP and other retinal degenerative diseases[1].
Product Specifications
UNSPSC
12352005
Target
PKG
Type
Reference compound
Related Pathways
Stem Cell/Wnt
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/dithio-cn03.html
Smiles
O=C1N2C(NC(C3=CC=CC=C3)=C2)=NC4=C1N=C(Br)N4C5O[C@H](COP(O6)(S)=S)[C@@H]6[C@H]5O.CCN(CC)CC
Molecular Formula
C24H30BrN6O5PS2
Molecular Weight
657.54
References & Citations
[1]Pérez O, et al. New Improved cGMP Analogues to Target Rod Photoreceptor Degeneration[J]. Journal of Medicinal Chemistry, 2024.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD171 / L1CAM (L1 Cell Adhesion Molecule) (UJ127), CF740 conjugate, 0.1mg/mL
CD81 / TAPA-1 (1.3.3.22), CF647 conjugate, 0.1mg/mL
CD63 (MX-49.129.5), CF555 conjugate, 0.1mg/mL
Human IgG Immunoglobulin (IG266), CF740 conjugate, 0.1mg/mL
